ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets

https://europepmc.org/article/PMC/PMC8482554

Synairgen’s wholly-owned lead programme SNG001 has potential value in three settings…

Interim results for the six months ended 30 June 2021

https://www.globenewswire.com/en/news-release/2021/09/30/2306031/0/en/Interim-results-for-the-six-months-ended-30-June-2021.html